GPX4 and cancer: Survival analysis revealed notable differences between GPX4 high- and low-expression groups for several cancer types; patients with high-GPX4 expression levels had significantly shorter OS than those with low-GPX4 expression in the TCGA-COAD cohort (Fig. 1B).